| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Cancer Biology, Sunnybrook Health Science Centre and Department of Medical Biophysics, University of Toronto, Toronto, Ontario M4N 3M5, Canada
Upon cytokine withdrawal, interleukin (IL) 6-dependent murine plasmacytoma/hybridoma (myeloma) cells die in a way characteristic of apoptosis. Although gene transfer-mediated elevation in Bcl-2 protein levels has been demonstrated to repress a number of apoptotic death programs, it has been reported that ectopic bcl-2 expression is unable to prolong the survival of IL-6-deprived myeloma cells. In view of the recent identification of Bax as a protein that antagonizes the anti-apoptotic function of Bcl-2, we sought to determine whether the inability of transfected bcl-2 to protect against myeloma cell apoptosis might simply be due to insufficient levels of Bcl-2 protein produced to counteract this inhibitor. We show here that high-level expression of an exogenous bcl-2 gene, introduced into IL-6-dependent B9 myeloma cells via retroviral or bovine papilloma virus-based vectors, is indeed able to suppress apoptotic death following cytokine deprivation, with the extent of protection provided correlating with the amount of Bcl-2 protein synthesized in relation to the amount of endogenous Bax protein present in the cells. Of note, however, we found that IL-6-mediated suppression of B9 apoptosis does not involve induction of endogenous bcl-2 expression but is associated instead with the up-regulation of cellular bcl-x mRNA and Bcl-xL protein. These results thus extend the apoptotic death mechanisms that are inhibitable by both bcl-2 and bcl-xL to include that operative in IL-6-dependent cells and suggest that apoptosis in other cell types using the gp130 subunit of the IL-6 receptor might also be bcl-2 regulable or bcl-xL dependent.
1 This work was supported in part by Grant 4510 from the National Cancer Institute of Canada and Grant MT-11749 from the Medical Research Council of Canada. M. M. K. S. was the recipient of a University of Toronto Open Scholarship. R. G. H. is a Career Scientist of the Ontario Cancer Treatment and Research Foundation.
2 To whom requests for reprints should be addressed, at Division of Cancer Biology, Reichmann Research Building, S218, Sunnybrook Health Science Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada.
Received 2/27/95. Accepted 4/21/95.
This article has been cited by other articles:
|
|
 |
|
  T. Khong, J. Sharkey, and A. Spencer The effect of azacitidine on interleukin-6 signaling and nuclear factor-{kappa}B activation and its in vitro and in vivo activity against multiple myeloma Haematologica, June 1, 2008; 93(6): 860 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wang, W. Zhang, P. Crisostomo, T. Markel, K. K. Meldrum, X. Y. Fu, and D. R. Meldrum Endothelial STAT3 plays a critical role in generalized myocardial proinflammatory and proapoptotic signaling Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2101 - H2108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wang, W. Zhang, P. Crisostomo, T. Markel, K. K. Meldrum, X. Y. Fu, and D. R. Meldrum Sex differences in endothelial STAT3 mediate sex differences in myocardial inflammation Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E872 - E877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Richardson, T. Hideshima, and K. C. Anderson Plasma cell dyscrasias ASH Self-Assessment Program, January 1, 2007; 2007(1): 298 - 327. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pedranzini, T. Dechow, M. Berishaj, R. Comenzo, P. Zhou, J. Azare, W. Bornmann, and J. Bromberg Pyridone 6, A Pan-Janus-Activated Kinase Inhibitor, Induces Growth Inhibition of Multiple Myeloma Cells Cancer Res., October 1, 2006; 66(19): 9714 - 9721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. R. Rezaee, C. Cunningham, A. J. Davison, and D. J. Blackbourn Kaposi's sarcoma-associated herpesvirus immune modulation: an overview J. Gen. Virol., July 1, 2006; 87(7): 1781 - 1804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yuan, F. J. Liddle, S. Mahajan, and D. A. Frank IL-6-induced survival of colorectal carcinoma cells is inhibited by butyrate through down-regulation of the IL-6 receptor Carcinogenesis, November 1, 2004; 25(11): 2247 - 2255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Brocke-Heidrich, A. K. Kretzschmar, G. Pfeifer, C. Henze, D. Loffler, D. Koczan, H.-J. Thiesen, R. Burger, M. Gramatzki, and F. Horn Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation Blood, January 1, 2004; 103(1): 242 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Stellrecht, C. O. Rodriguez Jr., M. Ayres, and V. Gandhi RNA-Directed Actions of 8-Chloro-Adenosine in Multiple Myeloma Cells Cancer Res., November 15, 2003; 63(22): 7968 - 7974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. W. C. J. van de Donk, M. M. J. Kamphuis, B. van Kessel, H. M. Lokhorst, and A. C. Bloem Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels Blood, November 1, 2003; 102(9): 3354 - 3362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Waxman, K. Mahboubi, R. G. Knickelbein, L. L. Mantell, N. Manzo, J. S. Pober, and J. A. Elias Interleukin-11 and Interleukin-6 Protect Cultured Human Endothelial Cells from H2O2-Induced Cell Death Am. J. Respir. Cell Mol. Biol., October 1, 2003; 29(4): 513 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tian, P. Gregoli, and M. Bondurant The function of the bcl-x promoter in erythroid progenitor cells Blood, March 15, 2003; 101(6): 2235 - 2242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Alas and B. Bonavida Inhibition of Constitutive STAT3 Activity Sensitizes Resistant Non-Hodgkin's Lymphoma and Multiple Myeloma to Chemotherapeutic Drug-mediated Apoptosis Clin. Cancer Res., January 1, 2003; 9(1): 316 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Pratt Molecular aspects of multiple myeloma Mol. Pathol., October 1, 2002; 55(5): 273 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J L Xu, R Lai, T Kinoshita, N Nakashima, and T Nagasaka Proliferation, apoptosis, and intratumoral vascularity in multiple myeloma: correlation with the clinical stage and cytological grade J. Clin. Pathol., July 1, 2002; 55(7): 530 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Greenstein, K. Ghias, N. L. Krett, and S. T. Rosen Mechanisms of Glucocorticoid-mediated Apoptosis in Hematological Malignancies Clin. Cancer Res., June 1, 2002; 8(6): 1681 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Zhang, I. Gojo, and R. G. Fenton Myeloid cell factor-1 is a critical survival factor for multiple myeloma Blood, March 15, 2002; 99(6): 1885 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-T. Lin, C.-Y. Juan, K.-J. Chang, W.-J. Chen, and M.-L. Kuo IL-6 inhibits apoptosis and retains oxidative DNA lesions in human gastric cancer AGS cells through up-regulation of anti-apoptotic gene mcl-1 Carcinogenesis, December 1, 2001; 22(12): 1947 - 1953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Birks, N. Latif, V. Owen, C. Bowles, L. E. Felkin, A. J. Mullen, A. Khaghani, P. J.R. Barton, J. M. Polak, J. R. Pepper, et al. Quantitative Myocardial Cytokine Expression and Activation of the Apoptotic Pathway in Patients Who Require Left Ventricular Assist Devices Circulation, September 18, 2001; 104(90001): I-233 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Alas, C. Emmanouilides, and B. Bonavida Inhibition of Interleukin 10 by Rituximab Results in Down-Regulation of Bcl-2 and Sensitization of B-cell Non-Hodgkin's Lymphoma to Apoptosis Clin. Cancer Res., March 1, 2001; 7(3): 709 - 723. [Abstract] [Full Text]
|
|
|
|
|
|
O. Hjertner, H. Hjorth-Hansen, M. Borset, C. Seidel, A. Waage, and A. Sundan Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells Blood, January 15, 2001; 97(2): 516 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kawamura, M. Kizaki, K. Yamato, H. Uchida, Y. Fukuchi, Y. Hattori, T. Koseki, T. Nishihara, and Y. Ikeda Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3 Blood, September 15, 2000; 96(6): 2005 - 2011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Negoro, K. Kunisada, E. Tone, M. Funamoto, H. Oh, T. Kishimoto, and K. Yamauchi-Takihara Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction Cardiovasc Res, September 1, 2000; 47(4): 797 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Dreyer, S. C. Phillips, M. L. Lindsey, P. Jackson, N. E. Bowles, L. H. Michael, and M. L. Entman Interleukin 6 induction in the canine myocardium after cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., August 1, 2000; 120(2): 256 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G. Willis and M. J. S. Dyer The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies Blood, August 1, 2000; 96(3): 808 - 822. [Full Text] [PDF]
|
|
|
|
|
|
N. S. Ward, A. B. Waxman, R. J. Homer, L. L. Mantell, O. Einarsson, Y. Du, and J. A. Elias Interleukin-6-Induced Protection in Hyperoxic Acute Lung Injury Am. J. Respir. Cell Mol. Biol., May 1, 2000; 22(5): 535 - 542. [Abstract] [Full Text]
|
|
|
|
|
|
C. Sanz, A. Benito, N. Inohara, D. Ekhterae, G. Nunez, and J. L. Fernandez-Luna Specific and rapid induction of the proapoptotic protein Hrk after growth factor withdrawal in hematopoietic progenitor cells Blood, May 1, 2000; 95(9): 2742 - 2747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Plowright, Z. Li, P. L. Bergsagel, M. Chesi, D. L. Barber, D. R. Branch, R. G. Hawley, and A. K. Stewart Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis Blood, February 1, 2000; 95(3): 992 - 998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hayashida, Y. Shimaoka, T. Ochi, and P. E Lipsky Rheumatoid Arthritis Synovial Stromal Cells Inhibit Apoptosis and Up-Regulate Bcl-xL Expression by B Cells in a CD49/CD29-CD106-Dependent Mechanism J. Immunol., January 15, 2000; 164(2): 1110 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gwechenberger, L. H. Mendoza, K. A. Youker, N. G. Frangogiannis, C. W. Smith, L. H. Michael, and M. L. Entman Cardiac Myocytes Produce Interleukin-6 in Culture and in Viable Border Zone of Reperfused Infarctions Circulation, February 2, 1999; 99(4): 546 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ayroldi, O. Zollo, L. Cannarile, F. D' Adamio, U. Grohmann, D. V. Delfino, and C. Riccardi Interleukin-6 (IL-6) Prevents Activation-Induced Cell Death: IL-2-Independent Inhibition of Fas/fasL Expression and Cell Death Blood, December 1, 1998; 92(11): 4212 - 4219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Voorzanger-Rousselot, M.-C. Favrot, and J.-Y. Blay Resistance to Cytotoxic Chemotherapy Induced by CD40 Ligand in Lymphoma Cells Blood, November 1, 1998; 92(9): 3381 - 3387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-h. Xu, S. Sharma, A. Gardner, Y. Tu, A. Raitano, C. Sawyers, and A. Lichtenstein Interleukin-6-Induced Inhibition of Multiple Myeloma Cell Apoptosis: Support for the Hypothesis That Protection Is Mediated Via Inhibition of the JNK/SAPK Pathway Blood, July 1, 1998; 92(1): 241 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Moore and Y. Chang Kaposi's Sarcoma-Associated Herpesvirus-Encoded Oncogenes and Oncogenesis J Natl Cancer Inst Monographs, April 1, 1998; 1998(23): 65 - 71. [Abstract] [Full Text]
|
|
|
|
|
|
J. L. Gommerman and S. A. Berger Protection From Apoptosis by Steel Factor But Not Interleukin-3 Is Reversed Through Blockade of Calcium Influx Blood, March 15, 1998; 91(6): 1891 - 1900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Siegel, X. Zhang, R. Feinman, T. Teitz, A. Zelenetz, V. M. Richon, R. A. Rifkind, P. A. Marks, and J. Michaeli Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates BCL-2 expression in human myeloma cells PNAS, January 6, 1998; 95(1): 162 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hallek, P. Leif Bergsagel, and K. C. Anderson Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process Blood, January 1, 1998; 91(1): 3 - 21. [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Jones and G. J. Gores Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine Am J Physiol Gastrointest Liver Physiol, December 1, 1997; 273(6): G1174 - G1188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tsunenari, Y. Koishihara, A. Nakamura, M. Moriya, H. Ohkawa, H. Goto, C. Shimazaki, M. Nakagawa, Y. Ohsugi, T. Kishimoto, et al. New Xenograft Model of Multiple Myeloma and Efficacy of a Humanized Antibody Against Human Interleukin-6 Receptor Blood, September 15, 1997; 90(6): 2437 - 2444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Molden, Y. Chang, Y. You, P. S. Moore, and M. A. Goldsmith A Kaposi's Sarcoma-associated Herpesvirus-encoded Cytokine Homolog (vIL-6) Activates Signaling through the Shared gp130 Receptor Subunit J. Biol. Chem., August 1, 1997; 272(31): 19625 - 19631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chauhan, S. Kharbanda, A. Ogata, M. Urashima, G. Teoh, M. Robertson, D. W. Kufe, and K. C. Anderson Interleukin-6 Inhibits Fas-Induced Apoptosis and Stress-Activated Protein Kinase Activation in Multiple Myeloma Cells Blood, January 1, 1997; 89(1): 227 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Berger and R. G. Hawley Interferon-beta Interrupts Interleukin-6-Dependent Signaling Events in Myeloma Cells Blood, January 1, 1997; 89(1): 261 - 271. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
